{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:04:50Z","timestamp":1761487490885},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.vaccine.2005.07.115","type":"journal-article","created":{"date-parts":[[2005,11,16]],"date-time":"2005-11-16T12:24:41Z","timestamp":1132143881000},"page":"95-101","source":"Crossref","is-referenced-by-count":12,"title":["Protective efficacy induced by Mycobacterium bovis bacille Calmette-Gu\u00e8rin can be augmented in an antigen independent manner by use of non-coding plasmid DNA"],"prefix":"10.1016","volume":"24","author":[{"given":"Philip J.","family":"Hogarth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen E.","family":"Logan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Candido","family":"Ferraz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Glyn","family":"Hewinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2005.07.115_bib1","series-title":"Bovine Tuberculosis in Cattle and Badgers","author":"Krebs","year":"1997"},{"issue":"1","key":"10.1016\/j.vaccine.2005.07.115_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0041-3879(91)90017-M","article-title":"The global tuberculosis situation and the new control strategy of the World Health Organization","volume":"72","author":"Kochi","year":"1991","journal-title":"Tubercle"},{"issue":"3","key":"10.1016\/j.vaccine.2005.07.115_bib3","doi-asserted-by":"crossref","first-page":"733","DOI":"10.20506\/rst.14.3.875","article-title":"Epidemiology of Mycobacterium bovis infection in animals and humans, with particular reference to Africa","volume":"14","author":"Cosivi","year":"1995","journal-title":"Rev Sci Tech"},{"key":"10.1016\/j.vaccine.2005.07.115_bib4","series-title":"Tuberculosis: Pathogenesis, Protection and Control","first-page":"531","article-title":"The BCG experience: implications for future vaccines against tuberculosis","author":"Bloom","year":"1994"},{"issue":"1\u20133","key":"10.1016\/j.vaccine.2005.07.115_bib5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1472-9792(02)00062-8","article-title":"Use of the bovine model of tuberculosis for the development of improved vaccines and diagnostics","volume":"83","author":"Hewinson","year":"2003","journal-title":"Tuberculosis (Edinb)"},{"issue":"3","key":"10.1016\/j.vaccine.2005.07.115_bib6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0966-842X(00)01949-1","article-title":"Tuberculosis vaccine development: recent progress","volume":"9","author":"Orme","year":"2001","journal-title":"Trends Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2005.07.115_bib7","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1084\/jem.178.6.2243","article-title":"Disseminated tuberculosis in interferon gamma gene-disrupted mice","volume":"178","author":"Cooper","year":"1993","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.vaccine.2005.07.115_bib8","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1084\/jem.178.6.2249","article-title":"An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection","volume":"178","author":"Flynn","year":"1993","journal-title":"J Exp Med"},{"issue":"11","key":"10.1016\/j.vaccine.2005.07.115_bib9","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0167-5699(98)01321-8","article-title":"Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria","volume":"19","author":"Ottenhoff","year":"1998","journal-title":"Immunol Today"},{"issue":"3","key":"10.1016\/j.vaccine.2005.07.115_bib10","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1164\/ajrccm.155.3.9116999","article-title":"IFN-gamma and IL-12 are increased in active compared with inactive tuberculosis","volume":"155","author":"Taha","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.vaccine.2005.07.115_bib11","doi-asserted-by":"crossref","first-page":"5393","DOI":"10.1128\/IAI.68.9.5393-5400.2000","article-title":"Distinct response kinetics of gamma interferon and interleukin-4 in bovine tuberculosis","volume":"68","author":"Rhodes","year":"2000","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2005.07.115_bib12","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1046\/j.1365-2567.2003.01589.x","article-title":"A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis","volume":"108","author":"Skinner","year":"2003","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.vaccine.2005.07.115_bib13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1046\/j.1365-2567.2001.01305.x","article-title":"Failure to induce enhanced protection against tuberculosis by increasing T-cell-dependent interferon-gamma generation","volume":"104","author":"Leal","year":"2001","journal-title":"Immunology"},{"issue":"6","key":"10.1016\/j.vaccine.2005.07.115_bib14","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1128\/IAI.70.6.3026-3032.2002","article-title":"Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis","volume":"70","author":"Vordermeier","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.115_bib15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.immunol.19.1.93","article-title":"Immunology of tuberculosis","volume":"19","author":"Flynn","year":"2001","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2005.07.115_bib16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.it.2003.11.009","article-title":"Jump-starting the immune system: prime-boosting comes of age","volume":"25","author":"Woodland","year":"2004","journal-title":"Trends Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2005.07.115_bib17","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1128\/IAI.69.6.4174-4176.2001","article-title":"Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosis","volume":"69","author":"Feng","year":"2001","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2005.07.115_bib18","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1128\/IAI.69.2.681-686.2001","article-title":"Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis","volume":"69","author":"McShane","year":"2001","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2005.07.115_bib19","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1128\/IAI.69.5.3041-3047.2001","article-title":"Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting","volume":"69","author":"Tanghe","year":"2001","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2005.07.115_bib20","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.1128\/IAI.71.9.4901-4907.2003","article-title":"A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis","volume":"71","author":"Skinner","year":"2003","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2005.07.115_bib21","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2567.2004.01903.x","article-title":"Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette-Guerin","volume":"112","author":"Vordermeier","year":"2004","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2005.07.115_bib22","series-title":"DNA Vaccines","first-page":"161","article-title":"DNA vaccines against bacterial pathogens","author":"Chambers","year":"2003"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2005.07.115_bib23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s002810000014","article-title":"The role of CpG in DNA vaccines","volume":"22","author":"McCluskie","year":"2000","journal-title":"Springer Semin Immunopathol"},{"issue":"8","key":"10.1016\/j.vaccine.2005.07.115_bib24","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/nm0896-888","article-title":"Vaccination against tuberculosis by DNA injection","volume":"2","author":"Tascon","year":"1996","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.vaccine.2005.07.115_bib25","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0264-410X(97)00073-X","article-title":"Protection against tuberculosis by a plasmid DNA vaccine","volume":"15","author":"Lowrie","year":"1997","journal-title":"Vaccine"},{"issue":"20\u201322","key":"10.1016\/j.vaccine.2005.07.115_bib26","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1016\/S0264-410X(01)00012-3","article-title":"Mixed immune response induced in rodents by two naked DNA genes coding for mycobacterial glycosylated proteins","volume":"19","author":"Garapin","year":"2001","journal-title":"Vaccine"},{"issue":"6741","key":"10.1016\/j.vaccine.2005.07.115_bib27","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/22326","article-title":"Therapy of tuberculosis in mice by DNA vaccination","volume":"400","author":"Lowrie","year":"1999","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.vaccine.2005.07.115_bib28","doi-asserted-by":"crossref","first-page":"7877","DOI":"10.1073\/pnas.1130426100","article-title":"The complete genome sequence of Mycobacterium bovis","volume":"100","author":"Garnier","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2005.07.115_bib29","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1017\/S0022172400052943","article-title":"A selective oleic acid albumin agar medium for the cultivation of Mycobacterium bovis","volume":"79","author":"Gallagher","year":"1977","journal-title":"J Hyg (Lond)"},{"issue":"6","key":"10.1016\/j.vaccine.2005.07.115_bib31","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nm881","article-title":"Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans","volume":"9","author":"McConkey","year":"2003","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.vaccine.2005.07.115_bib32","first-page":"423","article-title":"The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection","volume":"84","author":"Cooper","year":"1995","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.vaccine.2005.07.115_bib33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1084\/jem.186.1.39","article-title":"Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis","volume":"186","author":"Cooper","year":"1997","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.vaccine.2005.07.115_bib34","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1128\/IAI.68.5.2948-2953.2000","article-title":"CpG oligodeoxynucleotides and interleukin-12 improve the efficacy of Mycobacterium bovis BCG vaccination in mice challenged with M. tuberculosis.","volume":"68","author":"Freidag","year":"2000","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2005.07.115_bib35","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.4049\/jimmunol.158.8.3635","article-title":"Contribution of CpG motifs to the immunogenicity of DNA vaccines","volume":"158","author":"Klinman","year":"1997","journal-title":"J Immunol"},{"issue":"5273","key":"10.1016\/j.vaccine.2005.07.115_bib36","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1126\/science.273.5273.352","article-title":"Immunostimulatory DNA sequences necessary for effective intradermal gene immunization","volume":"273","author":"Sato","year":"1996","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.vaccine.2005.07.115_bib37","doi-asserted-by":"crossref","first-page":"6945","DOI":"10.1128\/IAI.72.12.6945-6950.2004","article-title":"A heterologous DNA priming-Mycobacterium bovis BCG boosting immunization strategy using mycobacterial Hsp70, Hsp65, and Apa antigens improves protection against tuberculosis in mice","volume":"72","author":"Ferraz","year":"2004","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2005.07.115_bib38","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1128\/IAI.70.10.5446-5453.2002","article-title":"Epitope mapping of the immunodominant antigen TB10.4 and the two homologous proteins TB10.3 and TB12.9, which constitute a subfamily of the esat-6 gene family","volume":"70","author":"Skjot","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.115_bib39","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1016\/j.vaccine.2004.11.030","article-title":"Protective immunity against Mycobacterium bovis induced by vaccination with Rv3109c\u2014a member of the esat-6 gene family","volume":"23","author":"Hogarth","year":"2005","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05011321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05011321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T21:09:38Z","timestamp":1706735378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X05011321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0264410X05011321"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2005.07.115","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}